Nitin Joshi, PhD, shared CAGE Bio’s development of CGB-500 and why phase 2 EASI scores have the company’s scientific advisory board optimistic.
Nitin Joshi, PhD
Advertisement
Articles by Nitin Joshi, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Dermatology Times - Dermatology News and Clinical Insights
1
Beyond the Rash: What Dermatologists Need to Know About the World of Infectious Diseases
2
A Practical Update on Psoriasis and Vitiligo Treatment
3
Nail Pathology in Clinical Practice with Phoebe Rich, MD
4
Adapting to the Age of AI in Clinical Dermatology
5
